Healthcare Specialist SHS Capital agreed to sell its portfolio company PathoQuest, a specialist in NGS-based quality control assays for biopharmaceuticals, to the strategic buyer Charles River Laboratories, a leading global provider of products and services that support drug discovery and non-clinical development. Founded in Paris, PathoQuest has established itself as a reference player in NGS-based viral safety and genetic characterisation testing for biopharmaceuticals. Its proprietary iDTECT® platform enables highly sensitive, comprehensive and GMP-compliant quality control, addressing the growing complexity of biologic modalities and increasing regulatory expectations.
Read the full article: Healthcare Specialist SHS Capital Agrees to Sell PathoQuest to Strategic Buyer Charles River Laboratories //
Source: https://www.eqs-news.com/news/corporate-news/healthcare-specialist-shs-capital-agreed-to-sell-pathoquest-to-strategic-buyer-charles-river-laboratories/f397bf71-6a5b-497b-bb1c-44fe5d3dc46a_en